• Edward Fang

    • Dr. Fang served as MicuRx’s Senior Vice President of clinical development since 2017 and Chief Medical Officer from 2020.
    • With over 15 years of experience in antibiotic drug development, he is responsible for the clinical development of MicuRx’s new drugs in the US and global multicenter clinical trials.
    • Dr. Fang was formerly the Chief Medical Officer at Adenium, responsible for clinical development strategy.
    • Prior to Adenium, he served as a director of clinical sciences of Trius, where he was the clinical lead for the development of Sivextro® (tedizolid). He was also an associate director at Cerexa, responsible for early phase clinical studies of ceftaroline.
    • Dr. Fang received his M.D. from the University of California, Los Angeles.